Mannkind (MNKD) Revenue Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 122.97% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.94% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 4.47% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 54.05% |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 30.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.44% |
| Dec 31, 2025 | 45.88% |
| Sep 30, 2025 | 35.76% |
| Jun 30, 2025 | 534.21% |
| Mar 31, 2025 | 86.95% |
| Dec 31, 2024 | 83.06% |
| Sep 30, 2024 | 46.67% |
| Jun 30, 2024 | 45.96% |
| Mar 31, 2024 | 56.05% |
| Dec 31, 2023 | 46.91% |
| Sep 30, 2023 | 49.46% |
| Jun 30, 2023 | 524.07% |
| Mar 31, 2023 | 35.76% |
| Dec 31, 2022 | 31.13% |
| Sep 30, 2022 | 260.61% |
| Jun 30, 2022 | 14.47% |
| Mar 31, 2022 | -11.75% |
| Dec 31, 2021 | -7.92% |
| Sep 30, 2021 | 70.66% |
| Jun 30, 2021 | 81.51% |
| Mar 31, 2021 | 71.36% |
| Dec 31, 2020 | 59.68% |
| Sep 30, 2020 | 95.87% |
| Jun 30, 2020 | -54.78% |
| Mar 31, 2020 | 75.39% |
| Dec 31, 2019 | 8.84% |
| Sep 30, 2019 | -83.72% |